Diagnostic biologique des angioedèmes bradykiniques : les recommandations du CREAK

Bradykinin mediated angioedema (BK-AE) can be associated either with C1Inhibitor deficiency (hereditary and acquired forms), either with normal C1Inh (hereditary form and drug induced AE as angiotensin converting enzyme inhibitors…). In case of high clinical suspicion of BK-AE, C1Inh exploration mus...

Full description

Saved in:
Bibliographic Details
Published inLa Presse médicale (1983) Vol. 48; no. 1; pp. 55 - 62
Main Authors Bouillet, Laurence, Defendi, Frederica, Hardy, Gaëlle, Cesbron, Jean-Yves, Boccon-Gibod, Isabelle, Deroux, Alban, Mansard, Catherine, Launay, David, Gompel, Anne, Floccard, Bernard, Jaussaud, Roland, Beaudouin, Etienne, Armengol, Guillaume, Olliver, Yann, Gayet, Stéphane, Du Than, Aureli, Sailler, Laurent, Guez, Stéphane, Sarrat, Anne, Sorin, Lucile, de Moreuil, Claire, Pelletier, Fabien, Javaud, Nicolas, Marmion, Nicolas, Fain, Olivier, Faure, Julien, Dumestre-Pérard, Chantal
Format Journal Article
LanguageFrench
Published Elsevier Masson 01.01.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Bradykinin mediated angioedema (BK-AE) can be associated either with C1Inhibitor deficiency (hereditary and acquired forms), either with normal C1Inh (hereditary form and drug induced AE as angiotensin converting enzyme inhibitors…). In case of high clinical suspicion of BK-AE, C1Inh exploration must be done at first: C1Inh function and antigenemy as well as C4 concentration. C1Inh deficiency is significant if the tests are below 50 % of the normal values and controlled a second time. In case of C1Inh deficiency, you have to identify hereditary from acquired forms. C1q and anti-C1Inh antibody tests are useful for acquired BK-AE. SERPING1 gene screening must be done if a hereditary angioedema is suspected, even if there is no family context (de novo mutation 15 %). If a hereditary BK-AE with normal C1Inh is suspected, F12 and PLG gene screening is suitable.
ISSN:0755-4982
2213-0276
DOI:10.1016/j.lpm.2018.06.015